ENTITY

Torrent Pharmaceuticals (TRP IN)

119

Analysis

Health Care • India

Torrent Pharmaceuticals Ltd. manufactures bulk drugs and pharmaceutical formulations. The Company's formulations include cardio-vascular, psychotropic and anti-biotic drugs while its bulk drugs include atenolol, ciprofloxacin and norfloxacin. Torrent Pharmaceuticals has wholly owned subsidiaries in several regulated and less regulated international markets.

more

Refresh

Exchange Announcement • 18 Jul 2024 13:20

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Exchange Announcement • 05 Jul 2024 21:37

TORRENT PHARMACEUTICALS LTD. - 500420 - Board Meeting Intimation for Consider And Approve The Audited Financial Results On Standalone Basis And Unaudited Financial Results (With Limited Review) On Consolidated Basis Of The Company For The Quarter Ended On 30-Jun-24.

Exchange Announcement • 03 Jul 2024 22:07

TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Exchange Announcement • 01 Jul 2024 17:58

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Exchange Announcement • 29 Jun 2024 22:15

TORRENT PHARMACEUTICALS LTD. - 500420 - Submission Of The Annual Report For The FY 2023-24 And The Notice Convening 51St Annual General Meeting Of The Company.

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x